Study to Investigate an Immunomodulatory Therapy in Adult Patients With Perennial Allergic Rhinoconjunctivitis

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE2

Total Enrollment

64 participants

Study Classification

INTERVENTIONAL

Study Start Date

2007-12-31

Study Completion Date

2009-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of the study is to test the efficacy of a vaccine against house dust mite and/or cat allergy compared to placebo in adult patients.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

A Study to Investigate an Immunomodulatory Therapy in Adult Patients With Perennial Allergic Rhinoconjunctivitis

NCT00574704

Perennial Allergic Rhinoconjunctivitis House Dust Mite Allergy

COMPLETED PHASE2

A Study to Investigate an Immunomodulatory Therapy in Adult Patients With Perennial Allergic Rhinoconjunctivitis

NCT00574223

Perennial Allergic Rhinoconjunctivitis House Dust Mite Allergy

COMPLETED PHASE2

Dose Finding Study With CYT003-QbG10 in Patients With House Dust Mite Allergy

NCT00800332

Rhinoconjunctivitis Allergies

COMPLETED PHASE2

Effect of an Allergen Vaccine in Patients With Allergic Rhino-Conjunctivitis and Asthma Due to House Dust Mite Allergy

NCT00652223

Perennial Allergic Rhinoconjunctivitis Allergic Asthma

COMPLETED PHASE1/PHASE2

A Multicenter Study to Evaluate Safety and Efficacy of Specific Immunotherapy With Modified Allergen Extracts

NCT01012752

Allergic Rhinitis Allergic Conjunctivitis

UNKNOWN PHASE3

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Perennial Allergy to House Dust Mite and/or Cat

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1

Group Type EXPERIMENTAL

CYT003-QbG10

Intervention Type DRUG

6 subcutaneous injections

2

Group Type PLACEBO_COMPARATOR

CYT003-QbG10

Intervention Type DRUG

6 subcutaneous injections

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

CYT003-QbG10

6 subcutaneous injections

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Mild to moderate perennial allergic rhinoconjunctivitis due to hypersensitization towards house dust mite and/or cat allergens

Exclusion Criteria

* Clinical relevant other allergies (perennial or seasonal) that could potentially interfere with the patient's study treatment schedule or assessments.
* Use of any concomitant medication that could affect the patient's study treatment response or assessment results.
* Any clinically relevant concomitant disease as judged by the investigator.
* Pregnancy or female planning to become pregnant during the study.

Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No